Khalid Raza

3.3k total citations
107 papers, 1.5k citations indexed

About

Khalid Raza is a scholar working on Molecular Biology, Computational Theory and Mathematics and Organic Chemistry. According to data from OpenAlex, Khalid Raza has authored 107 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Molecular Biology, 30 papers in Computational Theory and Mathematics and 14 papers in Organic Chemistry. Recurrent topics in Khalid Raza's work include Computational Drug Discovery Methods (28 papers), Synthesis and biological activity (13 papers) and Gene expression and cancer classification (13 papers). Khalid Raza is often cited by papers focused on Computational Drug Discovery Methods (28 papers), Synthesis and biological activity (13 papers) and Gene expression and cancer classification (13 papers). Khalid Raza collaborates with scholars based in India, Saudi Arabia and China. Khalid Raza's co-authors include Shaban Ahmad, Nripendra Kumar Singh, Sahar Qazi, N. A. Wani, Manoj Kumar Yadav, Meryam Sardar, Hemant K. Gautam, Mansaf Alam, Afreen Khan and Nafeesa Khatoon and has published in prestigious journals such as PLoS ONE, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Khalid Raza

101 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Khalid Raza India 23 558 352 172 170 122 107 1.5k
Haiping Zhang China 26 725 1.3× 308 0.9× 166 1.0× 79 0.5× 147 1.2× 155 2.1k
Bingding Huang China 18 1.1k 2.0× 543 1.5× 136 0.8× 88 0.5× 99 0.8× 59 2.1k
Ziyi Yang China 22 570 1.0× 468 1.3× 152 0.9× 128 0.8× 112 0.9× 67 1.3k
Huimin Guo China 27 762 1.4× 193 0.5× 122 0.7× 55 0.3× 222 1.8× 133 2.8k
Aman Chandra Kaushik China 25 923 1.7× 411 1.2× 53 0.3× 81 0.5× 119 1.0× 94 1.7k
Weilin Zhang China 14 972 1.7× 602 1.7× 192 1.1× 196 1.2× 43 0.4× 23 2.1k
Emma J. Chory United States 11 1.4k 2.5× 513 1.5× 133 0.8× 142 0.8× 143 1.2× 15 2.2k
Devesh Srivastava United States 14 488 0.9× 317 0.9× 87 0.5× 69 0.4× 113 0.9× 28 1.2k
Yifei Wang China 18 842 1.5× 442 1.3× 60 0.3× 85 0.5× 131 1.1× 90 1.9k

Countries citing papers authored by Khalid Raza

Since Specialization
Citations

This map shows the geographic impact of Khalid Raza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Khalid Raza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Khalid Raza more than expected).

Fields of papers citing papers by Khalid Raza

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Khalid Raza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Khalid Raza. The network helps show where Khalid Raza may publish in the future.

Co-authorship network of co-authors of Khalid Raza

This figure shows the co-authorship network connecting the top 25 collaborators of Khalid Raza. A scholar is included among the top collaborators of Khalid Raza based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Khalid Raza. Khalid Raza is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ahmad, Shaban, et al.. (2025). FDA-approved Levophed as an alternative multitargeted therapeutic against cervical cancer transferase, cell cycle, and regulatory proteins. Computers in Biology and Medicine. 191. 110163–110163. 2 indexed citations
3.
Sharma, Anjana, et al.. (2025). Nanoinformatics: Emerging technology for prediction and controlling of biological performance of nanomedicines. Computational Toxicology. 35. 100378–100378.
4.
Ahmad, Shaban, et al.. (2025). Machine learning for genomic profiling and drug discovery in personalised lung cancer therapeutics. Journal of drug targeting. 33(10). 1807–1826.
5.
6.
Ahmad, Shaban, et al.. (2024). Integrative analysis discovers Imidurea as dual multitargeted inhibitor of CD69, CD40, SHP2, lysozyme, GATA3, cCBL, and S-cysteinase from SARS-CoV-2 and M. tuberculosis. International Journal of Biological Macromolecules. 270(Pt 2). 132332–132332. 14 indexed citations
7.
Raza, Khalid. (2024). Machine Learning in Single-Cell RNA-seq Data Analysis. SpringerBriefs in applied sciences and technology. 1 indexed citations
8.
9.
Raza, Khalid, et al.. (2024). A Review on Picrosides Targeting NFκB and its Proteins for Treatment of Breast Cancer. Cell Biochemistry and Biophysics. 82(2). 575–591. 1 indexed citations
10.
Rana, Manish, Aysha Fatima, Shaban Ahmad, et al.. (2023). Synthesis, single crystal, TD-DFT, molecular dynamics simulation and DNA binding studies of carbothioamide analog. Journal of Molecular Structure. 1287. 135701–135701. 21 indexed citations
11.
Qazi, Sahar, et al.. (2023). DLC1 as Druggable Target for Specific Subsets of Gastric Cancer: An RNA-seq-Based Study. Medicina. 59(3). 514–514. 1 indexed citations
12.
Sahu, Ankita, Shaban Ahmad, Khalid Imtiyaz, et al.. (2023). In-silico and in-vitro study reveals ziprasidone as a potential aromatase inhibitor against breast carcinoma. Scientific Reports. 13(1). 16545–16545. 16 indexed citations
13.
Ahmad, Shaban, et al.. (2022). Reporting dinaciclib and theodrenaline as a multitargeted inhibitor against SARS-CoV-2: an in-silico study. Journal of Biomolecular Structure and Dynamics. 41(9). 4013–4023. 39 indexed citations
14.
Sharma, Nitin, Giriraj T. Kulkarni, Anant Narayan Bhatt, et al.. (2022). Therapeutic Options for the SARS-CoV-2 Virus: Is There a Key in Herbal Medicine?. Natural Product Communications. 17(9). 2 indexed citations
15.
Yadav, Manoj Kumar, et al.. (2022). Predictive modeling and therapeutic repurposing of natural compounds against the receptor-binding domain of SARS-CoV-2. Journal of Biomolecular Structure and Dynamics. 41(5). 1527–1539. 52 indexed citations
16.
Qazi, Sahar, et al.. (2022). Antiviral Potential of Indian Medicinal Plants Against Influenza and SARS-CoV: A Systematic Review. Natural Product Communications. 17(3). 12 indexed citations
17.
Rai, Arpita, Sahar Qazi, & Khalid Raza. (2020). In Silico Analysis and Comparative Molecular Docking Study of FDA Approved Drugs with Transforming Growth Factor Beta Receptors in Oral Submucous Fibrosis. Indian Journal of Otolaryngology and Head & Neck Surgery. 74(S2). 2111–2121. 8 indexed citations
18.
Raza, Khalid. (2018). Fuzzy logic based approaches for gene regulatory network inference. Artificial Intelligence in Medicine. 97. 189–203. 28 indexed citations
19.
Raza, Khalid, et al.. (2016). Principle, analysis, application and challenges of next-generation sequencing: a review. arXiv (Cornell University). 2 indexed citations
20.
Raza, Khalid, et al.. (2015). Ant colony optimization for inferring key gene interactions. International Conference on Computing for Sustainable Global Development. 1242–1246. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Haiping Zhang Breakdown of academic impact, for papers by Bingding Huang Breakdown of academic impact, for papers by Ziyi Yang Breakdown of academic impact, for papers by Huimin Guo Breakdown of academic impact, for papers by Aman Chandra Kaushik Breakdown of academic impact, for papers by Weilin Zhang Breakdown of academic impact, for papers by Emma J. Chory Breakdown of academic impact, for papers by Devesh Srivastava Breakdown of academic impact, for papers by Yifei Wang
Rankless by CCL
2026